Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System

被引:48
|
作者
Lochhead, Jeffrey J. [1 ]
Ronaldson, Patrick T. [1 ]
Davis, Thomas P. [1 ]
机构
[1] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA
来源
AAPS JOURNAL | 2017年 / 19卷 / 04期
关键词
blood-brain barrier; drug delivery; hypoxia; pain; tight junctions; OCCLUDIN OLIGOMERIC ASSEMBLIES; CORTICAL SPREADING DEPRESSION; SPINAL CORD BARRIER; LAMBDA-CARRAGEENAN; PROTEIN EXPRESSION; ABC TRANSPORTERS; BINDING PARTNERS; P-GLYCOPROTEIN; PERMEABILITY; CNS;
D O I
10.1208/s12248-017-0076-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A functional blood-brain barrier (BBB) is necessary to maintain central nervous system (CNS) homeostasis. Many diseases affecting the CNS, however, alter the functional integrity of the BBB. It has been shown that various diseases and physiological stressors can impact the BBB's ability to selectively restrict passage of substances from the blood to the brain. Modifications of the BBB's permeability properties can potentially contribute to the pathophysiology of CNS diseases and result in altered brain delivery of therapeutic agents. Hypoxia and/or inflammation are central components of a number of diseases affecting the CNS. A number of studies indicate hypoxia or inflammatory pain increase BBB paracellular permeability, induce changes in the expression and/or localization of tight junction proteins, and affect CNS drug uptake. In this review, we look at what is currently known with regard to BBB disruption following a hypoxic or inflammatory insult in vivo. Potential mechanisms involved in altering tight junction components at the BBB are also discussed. A more detailed understanding of the mediators involved in changing BBB functional integrity in response to hypoxia or inflammatory pain could potentially lead to new treatments for CNS diseases with hypoxic or inflammatory components. Additionally, greater insight into the mechanisms involved in TJ rearrangement at the BBB may lead to novel strategies to pharmacologically increase delivery of drugs to the CNS.
引用
收藏
页码:910 / 920
页数:11
相关论文
共 50 条
  • [31] In Vitro Models of the Blood-Brain Barrier for the Study of Drug Delivery to the Brain
    Wilhelm, Imola
    Krizbai, Istvan A.
    MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 1949 - 1963
  • [32] Immunologic privilege in the central nervous system and the blood-brain barrier
    Muldoon, Leslie L.
    Alvarez, Jorge I.
    Begley, David J.
    Boado, Ruben J.
    del Zoppo, Gregory J.
    Doolittle, Nancy D.
    Engelhardt, Britta
    Hallenbeck, John M.
    Lonser, Russell R.
    Ohlfest, John R.
    Prat, Alexandre
    Scarpa, Maurizio
    Smeyne, Richard J.
    Drewes, Lester R.
    Neuwelt, Edward A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (01) : 13 - 21
  • [33] Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier
    Campos, Christopher R.
    Ocheltree, Scott M.
    Hom, Sharon
    Egleton, Richard D.
    Davis, Thomas P.
    BRAIN RESEARCH, 2008, 1221 : 6 - 13
  • [34] Novel drug-delivery approaches to the blood-brain barrier
    Wang, Xiaoqing
    Yu, Xiaowen
    Vaughan, William
    Liu, Mingyuan
    Guan, Yangtai
    NEUROSCIENCE BULLETIN, 2015, 31 (02) : 257 - 264
  • [35] Caveolae-mediated transport at the injured blood-brain barrier as an underexplored pathway for central nervous system drug delivery
    Sorets, Alexander G.
    Rosch, Jonah C.
    Duvall, Craig L.
    Lippmann, Ethan S.
    CURRENT OPINION IN CHEMICAL ENGINEERING, 2020, 30 (30) : 86 - 95
  • [36] MicroRNAs in central nervous system diseases: A prospective role in regulating blood-brain barrier integrity
    Ma, Feifei
    Zhang, Xuejing
    Yin, Ke-Jie
    EXPERIMENTAL NEUROLOGY, 2020, 323
  • [37] Development of blood-brain barrier tight junctions in the rat cortex
    Kniesel, U
    Risau, W
    Wolburg, H
    DEVELOPMENTAL BRAIN RESEARCH, 1996, 96 (1-2): : 229 - 240
  • [38] Drug delivery to the brain in Alzheimer's disease: Consideration of the blood-brain barrier
    Banks, William A.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (07) : 629 - 639
  • [39] Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier
    Omidi, Yadollah
    Kianinejad, Nazanin
    Kwon, Young
    Omidian, Hossein
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (03) : 357 - 381
  • [40] Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system
    Zeniya, Satoshi
    Kuwahara, Hiroya
    Daizo, Kaiichi
    Watari, Akihiro
    Kondoh, Masuo
    Yoshida-Tanaka, Kie
    Kaburagi, Hidetoshi
    Asada, Ken
    Nagata, Tetsuya
    Nagahama, Masahiro
    Yagi, Kiyohito
    Yokota, Takanori
    JOURNAL OF CONTROLLED RELEASE, 2018, 283 : 126 - 134